Literature DB >> 12007180

A virtual screening method for prediction of the HERG potassium channel liability of compound libraries.

Olivier Roche1, Gerhard Trube, Jochen Zuegge, Pascal Pflimlin, Alexander Alanine, Gisbert Schneider.   

Abstract

A computer-based method has been developed for prediction of the hERG (human ether-à-go-go related gene) K(+)-channel affinity of low molecular weight compounds. hERG channel blockage is a major concern in drug design, as such blocking agents can cause sudden cardiac death. Various techniques were applied to finding appropriate molecular descriptors for modeling structure-activity relationships: substructure analysis, self-organizing maps (SOM), principal component analysis (PCA), partial least squares fitting (PLS), and supervised neural networks. The most accurate prediction system was based on an artificial neural network. In a validation study, 93 % of the nonblocking agents and 71 % of the hERG channel blockers were correctly classified. This virtual screening method can be used for general compound-library shaping and combinatorial library design.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007180     DOI: 10.1002/1439-7633(20020503)3:5<455::AID-CBIC455>3.0.CO;2-L

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  31 in total

1.  BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1.

Authors:  Mei Zhang; Yuliya V Korolkova; Jie Liu; Min Jiang; Eugene V Grishin; Gea-Ny Tseng
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

2.  A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1.

Authors:  Kamilla Angelo; Yuliya V Korolkova; Morten Grunnet; Eugene V Grishin; Kirill A Pluzhnikov; Dan A Klaerke; Hans-Günther Knaus; Morten Møller; Søren-Peter Olesen
Journal:  Pflugers Arch       Date:  2003-08-05       Impact factor: 3.657

3.  Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.

Authors:  Gaya Hettiarachchi; Soumen K Samanta; Shane Falcinelli; Ben Zhang; Damien Moncelet; Lyle Isaacs; Volker Briken
Journal:  Mol Pharm       Date:  2016-01-22       Impact factor: 4.939

4.  SOMMER: self-organising maps for education and research.

Authors:  Michael Schmuker; Florian Schwarte; André Brück; Ewgenij Proschak; Yusuf Tanrikulu; Alireza Givehchi; Kai Scheiffele; Gisbert Schneider
Journal:  J Mol Model       Date:  2006-09-22       Impact factor: 1.810

5.  Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data.

Authors:  Claire L Gavaghan; Catrin Hasselgren Arnby; Niklas Blomberg; Gert Strandlund; Scott Boyer
Journal:  J Comput Aided Mol Des       Date:  2007-03-24       Impact factor: 3.686

6.  Localization of the ergtoxin-1 receptors on the voltage sensing domain of hERG K+ channel by AFM recognition imaging.

Authors:  Lilia A Chtcheglova; Fatmahan Atalar; Ugur Ozbek; Linda Wildling; Andreas Ebner; Peter Hinterdorfer
Journal:  Pflugers Arch       Date:  2008-02-20       Impact factor: 3.657

7.  Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers.

Authors:  Khac-Minh Thai; Gerhard F Ecker
Journal:  Mol Divers       Date:  2009-02-14       Impact factor: 2.943

8.  Shape signatures: new descriptors for predicting cardiotoxicity in silico.

Authors:  Dmitriy S Chekmarev; Vladyslav Kholodovych; Konstantin V Balakin; Yan Ivanenkov; Sean Ekins; William J Welsh
Journal:  Chem Res Toxicol       Date:  2008-05-08       Impact factor: 3.739

9.  Cardio-vascular safety beyond hERG: in silico modelling of a guinea pig right atrium assay.

Authors:  Luca A Fenu; Ard Teisman; Stefan S De Buck; Vikash K Sinha; Ron A H J Gilissen; Marjoleen J M A Nijsen; Claire E Mackie; Wendy E Sanderson
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

10.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.